Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00490464 · ClinicalTrials.gov registry record
Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH
A clinical trial of Intracerebral Hemorrhage and Subarachnoid Hemorrhage, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- 163
- Enrollment target
- 1
- Study location
NCT00490464 is a study of Intracerebral Hemorrhage and Subarachnoid Hemorrhage that has completed, run by University of Illinois at Chicago. The registered enrollment target is 163 participants, below the 1,170-participant average among 29 other Intracerebral Hemorrhage trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00490464, a study of Intracerebral Hemorrhage and Subarachnoid Hemorrhage, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- 163 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to explore ways to improve and simplify control of blood pressure in patients with SAH or ICH. This research will be done by comparing tow different medications that are routinely used to help control blood pressure. None of the medications used in this study nor any procedures performed are experimental.
Conditions Studied
Interventions
- DRUG Nicardipine and Nipride
Study Locations (1)
Illinois
- University of Illinois at Chicago, UIC - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2004-06 |
| Est. Completion | 2007-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00490464
The ClinicalTrials.gov registry entry for NCT00490464 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,170-participant average among 29 other Intracerebral Hemorrhage trials with a reported enrollment target (86% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Intracerebral Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which Nicardipine and Nipride is the first listed.
NCT00490464 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00490464 about?
NCT00490464 is a clinical study titled "Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH". The purpose of this research is to explore ways to improve and simplify control of blood pressure in patients with SAH or ICH. This research will be done by comparing tow different medications that are routinely used to help control blood pressure. None of the medications used in this study nor any ...
What is the current status of trial NCT00490464?
This trial is currently completed. The enrollment target is 163 participants. The study started on 2004-06. Estimated completion is 2007-02.
What conditions does trial NCT00490464 study?
This clinical trial studies the following conditions: Intracerebral Hemorrhage, Subarachnoid Hemorrhage.
What interventions are being tested in trial NCT00490464?
The interventions under investigation include: Nicardipine and Nipride (DRUG).
Who is sponsoring clinical trial NCT00490464?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00490464 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracerebral Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hemodynamic ABI Monitor
RECRUITING
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
RECRUITING · Phase 3
-
Transitions of Care for Stroke Patients
RECRUITING
-
International Care Bundle Evaluation in Cerebral Hemorrhage Research
RECRUITING · Phase 4
-
ROSE-Longitudinal Assessment With Neuroimaging
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.